Adolor

Adolor Corporation, headquartered in Lionville, Pennsylvania, is a biopharmaceutical company focused on developing and commercializing prescription pain management products. The company employs 66 people and generates approximately $50 million in annual revenue. Adolor specializes in the discovery, development, and commercialization of novel pain management solutions. Their flagship product, ENTEREG® (alvimopan), is an FDA-approved medication that accelerates gastrointestinal recovery following bowel resection surgery. The company also has a robust research and development pipeline, including programs for chronic pain and opioid bowel dysfunction. Adolor distinguishes itself through its commitment to innovation and invention, driven by a dedication to addressing unmet medical needs in pain management. Their research collaborations with pharmaceutical giants like Pfizer Inc. highlight their commitment to advancing pain management therapies. For more information about Adolor Corporation and its products, visit www.adolor.com.